IDH1 and central nervous system cancer: Thus, the early histological division into low-grade (LGGs) and high-grade gliomas (HGGs) was gradually replaced by categories based on histological features and molecular biomarkers such as isocitrate dehydrogenase (IDH) mutation and 1p19q codeletion status [3].